Search

Gerald R. Ewoldt

Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1644
Total Applications
1060
Issued Applications
256
Pending Applications
142
Abandoned Applications
661

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7395475 [patent_doc_number] => 20040018195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Diabetes-related immunoglobulin derived proteins, compositions, methods and uses' [patent_app_type] => new [patent_app_number] => 10/397786 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 30308 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018195.pdf [firstpage_image] =>[orig_patent_app_number] => 10397786 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/397786
Diabetes-related immunoglobulin derived proteins, compositions, methods and uses Mar 25, 2003 Abandoned
Array ( [id] => 6829273 [patent_doc_number] => 20030180331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Facilitation of wound healing with CM101/GBS toxin' [patent_app_type] => new [patent_app_number] => 10/396770 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5059 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180331.pdf [firstpage_image] =>[orig_patent_app_number] => 10396770 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/396770
Facilitation of wound healing with CM101/GBS toxin Mar 23, 2003 Abandoned
Array ( [id] => 7290730 [patent_doc_number] => 20040110673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases' [patent_app_type] => new [patent_app_number] => 10/382397 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12491 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110673.pdf [firstpage_image] =>[orig_patent_app_number] => 10382397 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/382397
Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same Mar 5, 2003 Issued
Array ( [id] => 6769499 [patent_doc_number] => 20030215439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Therapeutic uses of PAF-AH products in diabetes' [patent_app_type] => new [patent_app_number] => 10/373639 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7261 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215439.pdf [firstpage_image] =>[orig_patent_app_number] => 10373639 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/373639
Therapeutic uses of PAF-AH products in diabetes Feb 23, 2003 Abandoned
Array ( [id] => 5743577 [patent_doc_number] => 20060089302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 10/505848 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10917 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089302.pdf [firstpage_image] =>[orig_patent_app_number] => 10505848 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/505848
Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases Feb 23, 2003 Abandoned
Array ( [id] => 6730250 [patent_doc_number] => 20030186440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Maturation of dendritic cells with immune response modifying compounds' [patent_app_type] => new [patent_app_number] => 10/354767 [patent_app_country] => US [patent_app_date] => 2003-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11241 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186440.pdf [firstpage_image] =>[orig_patent_app_number] => 10354767 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/354767
Maturation of dendritic cells with immune response modifying compounds Jan 29, 2003 Abandoned
Array ( [id] => 6822068 [patent_doc_number] => 20030220229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Proinsulin peptide compounds for detecting and treating type I diabetes' [patent_app_type] => new [patent_app_number] => 10/346563 [patent_app_country] => US [patent_app_date] => 2003-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14796 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220229.pdf [firstpage_image] =>[orig_patent_app_number] => 10346563 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/346563
Proinsulin peptide compounds for detecting and treating type I diabetes Jan 15, 2003 Abandoned
Array ( [id] => 6990811 [patent_doc_number] => 20050089848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'DNA molecules optimized sequences that encode the IA-2IC antigen, RNA molecules, expression vectors, transformed cells, method of preparing the IA-2IC antigen, polypeptide of the human IA-2IC antigen, and in vitro procedure and kit for the diagnonsis of autoimmune diabetes' [patent_app_type] => utility [patent_app_number] => 10/345307 [patent_app_country] => US [patent_app_date] => 2003-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6755 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089848.pdf [firstpage_image] =>[orig_patent_app_number] => 10345307 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/345307
DNA molecules optimized sequences that encode the IA-2IC antigen, RNA molecules, expression vectors, transformed cells, method of preparing the IA-2IC antigen, polypeptide of the human IA-2IC antigen, and in vitro procedure and kit for the diagnosis of autoimmune diabetes Jan 15, 2003 Issued
Array ( [id] => 6724989 [patent_doc_number] => 20030207301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Assay for the detection of factors that modulate the expression of INGAP' [patent_app_type] => new [patent_app_number] => 10/339767 [patent_app_country] => US [patent_app_date] => 2003-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15998 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207301.pdf [firstpage_image] =>[orig_patent_app_number] => 10339767 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/339767
Regulatory sequences for modulation of INGAP expression and reporter constructs Jan 8, 2003 Issued
Array ( [id] => 6669662 [patent_doc_number] => 20030114646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Human cystatin F' [patent_app_type] => new [patent_app_number] => 10/329428 [patent_app_country] => US [patent_app_date] => 2002-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23289 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114646.pdf [firstpage_image] =>[orig_patent_app_number] => 10329428 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/329428
Human cystatin F Dec 26, 2002 Abandoned
Array ( [id] => 7356057 [patent_doc_number] => 20040013676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same' [patent_app_type] => new [patent_app_number] => 10/312512 [patent_app_country] => US [patent_app_date] => 2002-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 10451 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20040013676.pdf [firstpage_image] =>[orig_patent_app_number] => 10312512 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/312512
Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same Dec 26, 2002 Abandoned
Array ( [id] => 7432570 [patent_doc_number] => 20040002113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Detection and treatment methods for type I diabetes' [patent_app_type] => new [patent_app_number] => 10/321717 [patent_app_country] => US [patent_app_date] => 2002-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14721 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002113.pdf [firstpage_image] =>[orig_patent_app_number] => 10321717 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/321717
Detection and treatment methods for type I diabetes Dec 16, 2002 Abandoned
Array ( [id] => 130780 [patent_doc_number] => 07700102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Nucleic acids encoding CD100 molecules' [patent_app_type] => utility [patent_app_number] => 10/320769 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 15 [patent_no_of_words] => 28928 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700102.pdf [firstpage_image] =>[orig_patent_app_number] => 10320769 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/320769
Nucleic acids encoding CD100 molecules Dec 15, 2002 Issued
Array ( [id] => 6972246 [patent_doc_number] => 20050037956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Screening method for agents useful in treating diabetes' [patent_app_type] => utility [patent_app_number] => 10/498587 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6868 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037956.pdf [firstpage_image] =>[orig_patent_app_number] => 10498587 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/498587
Screening method for agents useful in treating diabetes Dec 12, 2002 Abandoned
Array ( [id] => 7116239 [patent_doc_number] => 20050069540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Treating b-cell mediated diseases by modulating dr6 activity' [patent_app_type] => utility [patent_app_number] => 10/480109 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23489 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069540.pdf [firstpage_image] =>[orig_patent_app_number] => 10480109 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/480109
Treating b-cell mediated diseases by modulating dr6 activity Dec 9, 2002 Abandoned
Array ( [id] => 544850 [patent_doc_number] => 07169898 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-30 [patent_title] => 'Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells' [patent_app_type] => utility [patent_app_number] => 10/309611 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11892 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169898.pdf [firstpage_image] =>[orig_patent_app_number] => 10309611 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/309611
Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells Dec 3, 2002 Issued
Array ( [id] => 6864797 [patent_doc_number] => 20030190323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Preparations and methods for the treatment of T cell mediated diseases' [patent_app_type] => new [patent_app_number] => 10/307326 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10873 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190323.pdf [firstpage_image] =>[orig_patent_app_number] => 10307326 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/307326
Preparations and methods for the treatment of T cell mediated diseases Dec 1, 2002 Abandoned
Array ( [id] => 6710490 [patent_doc_number] => 20030170239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Immunotherapeutic method to prevent islet cell rejection' [patent_app_type] => new [patent_app_number] => 10/306860 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12044 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170239.pdf [firstpage_image] =>[orig_patent_app_number] => 10306860 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/306860
Immunotherapeutic method to prevent islet cell rejection Nov 25, 2002 Abandoned
Array ( [id] => 7429244 [patent_doc_number] => 20040001806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Preparation of dendritic cells from spinal cord stem cells' [patent_app_type] => new [patent_app_number] => 10/292152 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3474 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001806.pdf [firstpage_image] =>[orig_patent_app_number] => 10292152 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/292152
Preparation of dendritic cells from spinal cord stem cells Nov 11, 2002 Abandoned
Array ( [id] => 7155917 [patent_doc_number] => 20050026854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Selective elimination of cd52and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/495084 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9294 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026854.pdf [firstpage_image] =>[orig_patent_app_number] => 10495084 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/495084
Selective elimination of cd52and uses thereof Oct 31, 2002 Abandoned
Menu